Many cancer patients may need a sequential one-two punch of immunotherapies
Points to consider for studies of work participation in people with inflammatory arthritis
24 June 2021Younger adults are taking medications that could affect long term oral health
24 June 2021Many cancer patients may need a sequential one-two punch of immunotherapies
New research led by scientists at La Jolla Institute for Immunology (LJI) and the University of Liverpool may explain why many cancer patients do not respond to anti-PD-1 cancer immunotherapies—also called checkpoint inhibitors.
